Shopping Cart 0
Cart Subtotal
AED 0

Global Neurological Disorder Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10937

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 11671

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 21873

Details

Snapshot

The global Neurological Disorder Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neurological Disorder Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Antipsychotic

Hypnotic & Sedative

Analgesics

Anticoagulants

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Novartis AG

GlaxoSmithKline plc

Merck & Co.

Bayer AG

AstraZeneca

Boehringer Ingelheim GmbH

Teva Pharmaceutical Industries Ltd

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital

Clinic

Home

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Neurological Disorder Drugs Industry

1.1.1 Overview

1.1.2 Development of Neurological Disorder Drugs

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Neurological Disorder Drugs Market by Type

3.1 By Type

3.1.1 Antipsychotic

3.1.2 Hypnotic & Sedative

3.1.3 Analgesics

3.1.4 Anticoagulants

3.1.5 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Neurological Disorder Drugs Novartis AG (Company Profile, Sales Data etc.)

4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)

4.3 Merck & Co. (Company Profile, Sales Data etc.)

4.4 Bayer AG (Company Profile, Sales Data etc.)

4.5 AstraZeneca (Company Profile, Sales Data etc.)

4.6 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)

4.7 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital

6.1.2 Demand in Clinic

6.1.3 Demand in Home

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Neurological Disorder Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Neurological Disorder Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Neurological Disorder Drugs Market Concentration, in 2018

Figure Europe Neurological Disorder Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Neurological Disorder Drugs MMarket Concentration, in 2018

Figure South America Neurological Disorder Drugs Market Concentration, in 2018

Figure Middle East & Africa Neurological Disorder Drugs Market Concentration, in 2018

Figure Neurological Disorder Drugs Demand in Hospital, 2013-2018, in USD Million

Figure Neurological Disorder Drugs Demand in Hospital, 2013-2018, in Volume

Figure Neurological Disorder Drugs Demand in Clinic, 2013-2018, in USD Million

Figure Neurological Disorder Drugs Demand in Clinic, 2013-2018, in Volume

Figure Neurological Disorder Drugs Demand in Home, 2013-2018, in USD Million

Figure Neurological Disorder Drugs Demand in Home, 2013-2018, in Volume

Figure North America Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Neurological Disorder Drugs

Table Application Segment of Neurological Disorder Drugs

Table Global Neurological Disorder Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Antipsychotic

Table Major Company List of Hypnotic & Sedative

Table Major Company List of Analgesics

Table Major Company List of Anticoagulants

Table Major Company List of Others

Table Global Neurological Disorder Drugs Market 2013-2018, by Type, in USD Million

Table Global Neurological Disorder Drugs Market 2013-2018, by Type, in Volume

Table Global Neurological Disorder Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Neurological Disorder Drugs Market Forecast 2019-2024, by Type, in Volume

Table Novartis AG Overview List

Table Neurological Disorder Drugs Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline plc Overview List

Table Neurological Disorder Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co. Overview List

Table Neurological Disorder Drugs Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer AG Overview List

Table Neurological Disorder Drugs Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Neurological Disorder Drugs Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim GmbH Overview List

Table Neurological Disorder Drugs Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Industries Ltd Overview List

Table Neurological Disorder Drugs Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Neurological Disorder Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Neurological Disorder Drugs Sales Revenue Share, by Company, in USD Million

Table Global Neurological Disorder Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Neurological Disorder Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Neurological Disorder Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Neurological Disorder Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Neurological Disorder Drugs Production 2013-2018, by Region, in USD Million

Table Neurological Disorder Drugs Production 2013-2018, by Region, in Volume

Table Global Neurological Disorder Drugs Market 2013-2018, by Region, in USD Million

Table Global Neurological Disorder Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Neurological Disorder Drugs Market 2013-2018, by Region, in Volume

Table Global Neurological Disorder Drugs Market Share 2013-2018, by Region, in Volume

Table North America Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table South America Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Neurological Disorder Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Neurological Disorder Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Snapshot

The global Neurological Disorder Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neurological Disorder Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Antipsychotic

Hypnotic & Sedative

Analgesics

Anticoagulants

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Novartis AG

GlaxoSmithKline plc

Merck & Co.

Bayer AG

AstraZeneca

Boehringer Ingelheim GmbH

Teva Pharmaceutical Industries Ltd

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital

Clinic

Home

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Neurological Disorder Drugs Industry

1.1.1 Overview

1.1.2 Development of Neurological Disorder Drugs

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Neurological Disorder Drugs Market by Type

3.1 By Type

3.1.1 Antipsychotic

3.1.2 Hypnotic & Sedative

3.1.3 Analgesics

3.1.4 Anticoagulants

3.1.5 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Neurological Disorder Drugs Novartis AG (Company Profile, Sales Data etc.)

4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)

4.3 Merck & Co. (Company Profile, Sales Data etc.)

4.4 Bayer AG (Company Profile, Sales Data etc.)

4.5 AstraZeneca (Company Profile, Sales Data etc.)

4.6 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)

4.7 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital

6.1.2 Demand in Clinic

6.1.3 Demand in Home

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Neurological Disorder Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Neurological Disorder Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Neurological Disorder Drugs Market Concentration, in 2018

Figure Europe Neurological Disorder Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Neurological Disorder Drugs MMarket Concentration, in 2018

Figure South America Neurological Disorder Drugs Market Concentration, in 2018

Figure Middle East & Africa Neurological Disorder Drugs Market Concentration, in 2018

Figure Neurological Disorder Drugs Demand in Hospital, 2013-2018, in USD Million

Figure Neurological Disorder Drugs Demand in Hospital, 2013-2018, in Volume

Figure Neurological Disorder Drugs Demand in Clinic, 2013-2018, in USD Million

Figure Neurological Disorder Drugs Demand in Clinic, 2013-2018, in Volume

Figure Neurological Disorder Drugs Demand in Home, 2013-2018, in USD Million

Figure Neurological Disorder Drugs Demand in Home, 2013-2018, in Volume

Figure North America Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Neurological Disorder Drugs

Table Application Segment of Neurological Disorder Drugs

Table Global Neurological Disorder Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Antipsychotic

Table Major Company List of Hypnotic & Sedative

Table Major Company List of Analgesics

Table Major Company List of Anticoagulants

Table Major Company List of Others

Table Global Neurological Disorder Drugs Market 2013-2018, by Type, in USD Million

Table Global Neurological Disorder Drugs Market 2013-2018, by Type, in Volume

Table Global Neurological Disorder Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Neurological Disorder Drugs Market Forecast 2019-2024, by Type, in Volume

Table Novartis AG Overview List

Table Neurological Disorder Drugs Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline plc Overview List

Table Neurological Disorder Drugs Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck & Co. Overview List

Table Neurological Disorder Drugs Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer AG Overview List

Table Neurological Disorder Drugs Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Neurological Disorder Drugs Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim GmbH Overview List

Table Neurological Disorder Drugs Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Industries Ltd Overview List

Table Neurological Disorder Drugs Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Neurological Disorder Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Neurological Disorder Drugs Sales Revenue Share, by Company, in USD Million

Table Global Neurological Disorder Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Neurological Disorder Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Neurological Disorder Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Neurological Disorder Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Neurological Disorder Drugs Production 2013-2018, by Region, in USD Million

Table Neurological Disorder Drugs Production 2013-2018, by Region, in Volume

Table Global Neurological Disorder Drugs Market 2013-2018, by Region, in USD Million

Table Global Neurological Disorder Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Neurological Disorder Drugs Market 2013-2018, by Region, in Volume

Table Global Neurological Disorder Drugs Market Share 2013-2018, by Region, in Volume

Table North America Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table South America Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Neurological Disorder Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Neurological Disorder Drugs Market Size 2013-2018, by Country, in Volume

Table Neurological Disorder Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Neurological Disorder Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS